Rapid Readouts: Phase 2 Study of Navitoclax in High-Risk Myelofibrosis

Video

Related Videos
Lori A. Leslie, MD
Changchun Deng, MD, PhD
Rebecca Klisovic, MD
Guenther Koehne, MD, PhD
Sunil Iyer, MD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center